Product identity
What it is
Active ingredient or category: Turmeric preparations and curcuminoids
Regulatory classification: Dietary supplements; topical products also marketed
What official sources say
- NCCIH identifies osteoarthritis among common promotional uses and evaluates usefulness and safety separately.
- Dietary supplements are not FDA-approved for safety and effectiveness before marketing.
Questions to take to a clinician or pharmacist
- What exact formulation, amount, and additional ingredients are in the product?
- What evidence applies to that formulation and diagnosed condition?
- Could it interact with anticoagulants or other medicines, or affect a health condition?
Sources reviewed
Links open the authoritative source. Product labels and guidance can change; verify the current version before relying on any summary.
- NCCIH: Turmeric—usefulness and safety
- NCCIH: Nutritional approaches for musculoskeletal inflammation
- FDA: Is it really FDA approved?
More in Complementary
Glucosamine + chondroitin
Glucosamine and chondroitin are widely marketed for osteoarthritis and joint health. NCCIH reports inconsistent study results and meaningful differences among professional guidelines and product formulations.
Read source profileOmega-3 supplements
NCCIH reports some evidence of modest symptom benefit in rheumatoid arthritis, but omega-3 supplements are not disease-modifying replacements for prescribed treatment.
Read source profileBoswellia
Small studies of oral boswellia suggest possible osteoarthritis symptom effects, but NCCIH says larger, higher-quality studies are needed and topical evidence is insufficient.
Read source profile